Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients
- PMID: 20566859
- PMCID: PMC2901467
- DOI: 10.1073/pnas.0914079107
Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients
Abstract
It was recently reported that rs1541160 on chromosome 1q24.2 has a marked effect on survival of amyotrophic lateral sclerosis (ALS) patients by influencing KIFAP3 expression. The cohorts used in that study were collected from ALS specialty clinics. We attempted to replicate these findings in a population-based cohort of 504 Italian ALS patients. None of 140 SNPs genotyped within the KIFAP3 locus (including rs1541160) had an effect on survival (log-rank P value for rs1541160 = 0.47) or on gene expression in that region. These data illustrate the complexities associated with analyzing ALS phenotypes for association.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Chancellor AM, et al. The prognosis of adult-onset motor neuron disease: A prospective study based on the Scottish Motor Neuron Disease Register. J Neurol. 1993;240:339–346. - PubMed
-
- del Aguila MA, Longstreth WT, Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: A population-based study. Neurology. 2003;60:813–819. - PubMed
-
- Millul A, et al. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology. 2005;25:114–119. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
